KARDIAMET TABLETS 2.5mg & 5mg

Kardiamet (Vericiguat) 2.5 mg and 5 mg Tablets is an oral soluble guanylate cyclase (sGC) stimulator indicated for the treatment of symptomatic chronic heart failure in adult patients with reduced ejection fraction. Vericiguat enhances the nitric oxide–sGC–cyclic guanosine monophosphate (cGMP) pathway, leading to improved myocardial and vascular function. By restoring impaired NO signaling, it helps reduce the risk of cardiovascular death and heart failure hospitalization. Kardiamet provides a novel oral therapeutic option for optimized heart failure management.